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Abstract: Objective methods for examination of pouch function are warranted for a better 
understanding of the functional result and treatment of dysfunction. The objective of this 
study was to evaluate the results of scintigraphic intestinal transit time and defaecography 
compared to the results of pouch function, mucosal condition and a questionnaire on quality 
of life (QoL). This cross-sectional study included 21 patients. Scintigraphic transit time and 
defaecography was determined with the use of Tc-99m. Pouch function was assessed by number 
of bowel movements, pouch volume, and continence. Pouch mucosal condition was evaluated 
by endoscopy and histology. Median transit time was 189 min (105–365). Median ejection 
fraction at defaecography (EF) was 49% (3–77) and 62% (17–98) after first and second 
defecation. Median pouch volume was 223 mL (100–360). A median daily stool frequency 
of nine (4–25) was reported and three (14%) patients suffered from daytime incontinence. 
No patients had symptomatic or endoscopic pouchitis; however, the histology showed 
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unspecific inflammation in 19 (90%) patients. There was no correlation between transit time, 
evacuation fraction (EF) and pouch function in univariate analysis. However, we found a 
high body mass index (BMI) and a low bowel movement frequency to be associated with a 
longer transit time by multivariate analysis. Scintigraphic determination of transit time and 
defaecography are feasible methods in patients with ileal pouch anal anastomosis, but the 
clinical relevance is yet doubtful. 
Keywords: scintigraphic small intestinal transit time; scintigraphic defaecography;  
ileal pouch-anal anastomosis; IPAA; ulcerative colitis 
 
1. Introduction 
Proctocolectomy and subsequent reconstruction with an ileal pouch-anal anastomosis (IPAA) for 
ulcerative colitis aims to eliminate the disease, avoid a permanent stoma, and result in acceptable pouch 
function along with good quality of life (QoL). The definition of pouch function is very heterogeneous, 
and can include various aspects, such as stool frequency, urgency, incontinence, incomplete emptying, 
use of pads, and anti-diarrheal medication. 
A recent systemic review found a mean (95% CI) stool frequency of 5.9 (5.0–6.9) per 24-hour within 
5132 adult IPAA patients and severe daytime incontinence in 6.1% (2.9–12.3) among 3718 patients [1]. 
A new Swedish study concluded that more than 35% of patients had a stool frequency of six or more 
regardless of pouch design and type of anastomosis [2]. Stool frequency varies from day to day. Patients’ 
perception of problems with frequent bowel movements also varies; some may easily tolerate more than 
10 stools per day. 
Several self-reporting scoring systems exist to evaluate the pouch function [3–5], however no good 
simple objective measures exist to explain the functional outcome. Some studies have shown that daily 
stool frequency and pouch volume are inversely related, yet others recommend an optimal volume 
around 200 mL [6,7]. Other studies have indicated a relationship between pouch evacuation fraction 
(EF) and function [8–10]. 
Another reason for high stool frequency could be differences in the small intestinal transit time. Only 
few studies with oral administration of tracer have investigated transit time in IPAA patients and mainly 
with a radiopaque marker or barium [11–13]. Scintigraphic assessment of the transit time has been 
investigated in only a few minor studies [14,15]. A reliable method for measurement of small intestinal 
transit time would be clinically relevant, since subjects with rapid transit could be assumed to benefit 
from pharmacological intervention. 
The aim of this study was to evaluate the feasibility of a clinical simple scintigraphic method for 
measurement of small intestinal transit time and pouch evacuation in IPAA patients and to investigate 
any relation with pouch function and QoL. 
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2. Experimental Section 
We conducted a cross-sectional study in a Danish University Hospital centre (Odense, Denmark). The 
study was carried out in accordance with the Declaration of Helsinki and with approval by the National 
Committee on Health Research Ethics and the Danish Data Protection Agency (Copenhagen, Denmark). 
Our goal was to include 20 adult patients with histological diagnosis of ulcerative colitis followed by 
proctocolectomy and reconstruction of an IPAA. Letter for invitation was sent to 40 randomly selected 
patients with a functioning IPAA. All patients had a J-pouch design and both patients operated with 
laparoscopic assisted and open IPAA surgery were included. The staging of IPAA was defined as:  
(1-stage) proctocolectomy and IPAA in one operation without diversion, (2-stage) proctocolectomy and 
IPAA with faecal diversion and later stoma closure, (3-stage) subtotal colectomy, IPAA and closure of 
diverting stoma in three different operations. Patients with co-morbidity contraindicating endoscopy or 
pregnancy were excluded. 
All patients gave written informed consent prior to examinations. 
2.1. Questionnaires 
Pouch function in terms of stool frequency and incontinence was evaluated by a self-reported 
questionnaire. Minor and major incontinence were defined as seepage and stool incontinence, 
respectively. QoL was estimated by a validated questionnaire, the Short Inflammatory Bowel Disease 
Questionnaire (SIBDQ) ranging from 10 to 70 were 70 represents optimal QoL [16,17]. 
2.2. Inflammation 
Inflammation was evaluated by endoscopy, pouch biopsy and faecal level of calprotectin. Histology 
was evaluated by an experienced pathologist and inflammation was defined as polymorphonuclear 
infiltration of lamina propria, and divided in mild, moderate and severe depending on the severity and 
presence of crypt abscesses. 
2.3. Scintigraphy 
Two separate scintigraphic examinations were performed in each enrolled patient: a defaecography 
and an investigation of the intestinal transit time. The overall effective radiation dose was 2.3 mSv for 
each patient. 
Intestinal transit time was determined after oral administration of an omelette labelled with 50 MBq 
technetium-99m (Tc-99m) together with 200 mL of water. The caloric content of the 100 g omelette was 
1400 kJ with 60% carbohydrate, 20% fat, and 20% protein. Abdominal scintigrams of 2 min were 
obtained with a dual headed gamma camera equipped with LEHR collimators, matrix 128 × 128,  
in both anterior and posterior projections every 15 min until the tracer was visually cleared from the 
stomach and the majority of the activity had reached the pouch (Figure 1). This was determined 
qualitatively with help from anatomic markers and acceptable number of images in every patient.  
The first acquisition began within 5 min of completing the meal. To obtain alignment of scintigrams and 
determine anatomic landmarks the anterior superior iliac spine and os coccyx were marked on each 
image with a tracer pen. The patients were supine during the recordings and were allowed to sit, stand 
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and walk in between. They were fasting 6 h prior to the investigation and ingestion of food and liquid 
was allowed 3 h after ingestion of the tracer-labelled omelette, and only one patient declined this offer. 
All medication was taken habitually prior to and during the study. These actions were not standardized, 
as individual habitual physiological measurements were desired. 
 
Figure 1. Scintigraphic small intestinal transit time. Anterior and posterior projection.  
(A) 0 min, (B) 75 min, (C) 105 min, (D) 360 min; a: Stomach, b: Loop of small intestine, c: 
Pouch, d: Anatomic markers, in terms of the anterior superior iliac spine and os coccyx. 
Modelling of the intestinal transit time. The method described in the present study was inspired by 
the convolution method by Brinch et al. [18]. Regions of interest (ROIs) over the stomach, small 
intestine, and pouch were drawn manually on all time frames based on visual assessment of sequential 
scans. It was defined as visible radioactivity within the small intestine. Geometric mean images were 
calculated to partially eliminate tissue attenuation. Time activity curves were derived from the geometric 
mean images and decay corrected. The same physicist performed all analyses. 
The time activity curve ܴܱܫ௦௠௔௟௟	௜௡௧௘௦௧௜௡௘  of the small intestine was modelled individually by 
convolution of the input curve from the stomach ݏሺݐሻ	with a small intestinal impulse response function 
݂ሺݐሻ, see equation (1) 
ܴܱܫ௦௠௔௟௟	௜௡௧௘௦௧௜௡௘ሺݐሻ ≅ ሺ݂ ∗ ݏሻሺݐሻ ൌ න ݂ሺ߬ሻݏሺݐ െ ߬ሻ݀߬
ஶ
଴
 (1)
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The small intestinal impulse response function ݂ሺݐሻ is the probability [0;1] that a given input remains 
in the small intestine after a time period t. The small intestinal impulse response function	݂ሺݐሻ	was 
assumed to be a dimensionless smooth step function 
݂ሺݐሻ ൌ 1 ൅ ݁
ି஑ ஒ⁄
1 ൅ ݁ሺ௧ି஑ሻ ஒ⁄  (2)
When activity enters the small intestine a spectrum of different transit/residence times occurs. The  
α parameter (time) describes the point in time where activity begins to leave the small intestine and  
β (time) is a measure of deviation between transit times, a large β value yields a very narrow spectrum 
of transit times. 
The input function from the gastric emptying ݏሺݐሻ (counts/time) is calculated as the amount of tracer 
that has left the stomach in the period ݀ݐ 
ݏሺݐሻ ൌ െܴܱ݀ܫ௚௔௦௧௥௜௖ሺݐሻ݀ݐ  (3)
The mean transit time ݐ௦̅௜of the small intestine is the integral of the time activity curve of the small 
intestine divided by the initial activity ܣ଴	(counts) 
ݐ௦̅௜ ൌ
׬ ܴܱܫ௦௠௔௟௟ ௜௡௧௘௦௧௜௡௘ሺݐሻ݀ݐஶ଴
ܣ଴  (4)
Calculating the mean intestinal transit time from the complete activity curve ܴܱܫ௦௠௔௟௟	௜௡௧௘௦௧௜௡௘	 
requires knowledge of the entire activity curve, which often requires to image beyond 6 h. Instead we 
simply calculate the mean transit time ݐ௦̅௜ from the time integral of the impulse response function ݂ 
ݐ௦̅௜ ൌ 	 ׬ ோைூೞ೘ೌ೗೗	೔೙೟೐ೞ೟೔೙೐ሺ௧ሻௗ௧
ಮ
బ
஺బ ≅
׬ ሺ௙∗௦ሻௗ௧ಮబ
஺బ ൌ
׬ ௦ሺ௧ሻௗ௧ಮబ
஺బ ׬ ݂ሺݐሻ݀ݐ
ஶ
଴  = ׬ ݂ሺݐሻ݀ݐ
ஶ
଴  (5)
The parameters α and β describing the impulse response function ݂ was calculated by means of 
minimizing the sum of least squares between the measured curve ܴܱܫ௦௠௔௟௟	௜௡௧௘௦௧௜௡௘ሺݐሻ and the calculated 
convolution curve ሺ݂ ∗ ݏሻሺݐሻ  in equation (1). Due to attenuation differences between stomach and 
abdominal regions [19] a small scaling factor was included in the fitting procedure. 
The gastric mean transit time ݐ௚̅௔௦௧௥௜௖	was calculated as the integral of the time activity curve of  
the stomach 
ݐ௚̅௔௦௧௥௜௖ ൌ
׬ ܴܱܫ ݀ݐஶ଴
ܣ଴  (6) 
2.4. Defaecography 
On a separate day, a scintigraphic defaecography was performed with per anal instillation of a paste 
containing water and methyl cellulose in the ratio 350 mL/16 g and labelled with 0.23 MBq  
Tc-99m-sulphur colloid/mL. Instillation was continued until the patient felt the urge to defaecate and the 
instilled volume was recorded. Pouch volume was estimated from the instilled paste. A 10 min 
scintigraphic acquisition with a dual headed gamma camera equipped with LEHR collimators and matrix 
128 × 128. Anterior and posterior images was performed before and after defaecation and repeated after 
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a second defaecation one hour later. Pouch EF was calculated from geometric mean values of counts in 
ROIs drawn on the scintigrams as (def: defaecation): 
ܧܨ	ܣ	 ൌ ሺܿ݋ݑ݊ݐݏ ݅݊	ܴܱܫݏ	ܾ݂݁݋ݎ݁ ݂݀݁ ܣ െ ܿ݋ݑ݊ݐݏ ݅݊ ܴܱܫݏ ݂ܽݐ݁ݎ ݂݀݁	ܣሻܿ݋ݑ݊ݐݏ ݅݊ ܴܱܫݏ ܾ݂݁݋ݎ݁ ݂݀݁ ܣ 	ൈ 	100% 
(7)
ܧܨ	ܤ	 ൌ ሺܿ݋ݑ݊ݐݏ ݅݊	ܴܱܫݏ	ܾ݂݁݋ݎ݁ ݂݀݁ ܣ െ ܿ݋ݑ݊ݐݏ ݅݊ ܴܱܫݏ ݂ܽݐ݁ݎ ݂݀݁	ܤሻܿ݋ݑ݊ݐݏ ݅݊ ܴܱܫݏ ܾ݂݁݋ݎ݁ ݂݀݁ ܣ 	ൈ 	100% 
(8)
2.5. Statistics 
Variables were analysed descriptively according to data type, i.e., continuous variables were 
expressed by median and range, categorical variables as frequency counts including respective 
percentages. Univariate correlations were studied with Spearman’s rank correlation coefficient. Transit 
time and EF were dependent variables, and p-values for correlations were designated Ptransit and PEF, 
respectively. A multivariate linear regression model was made adjusting for potential confounders 
including independent variables selected from clinical relevance. Potential confounders included age, 
sex, body mass index (BMI), stool frequency, pouch volume, histologic inflammation, and EF. Due to 
the limited sample size, multivariate analyses were of exploratory nature. A two-tailed significance level 
of 5% was used. Missing data were handled using list-wise deletion. Stata/IC 13 (StataCorp LP, College 
Station, TX, USA) was used for statistical analysis. 
3. Results 
3.1. Patients and Baseline Characteristics 
From January 2012 through May 2013 we included 21 patients well represented in relation to sex, 
time since IPAA surgery, and complications compared with non-respondents. Due to intercurrent 
pregnancy one patient did not undergo the additional investigation of transit time; hence, only data from 
20 patients were included in the final analyses of this parameter. 
Patient characteristics, results from the questionnaires and evaluation of pouch inflammation are 
given in Table 1. Median time from IPAA operation to participation was 932 days (481–3491). In our 
patient group 14 (67%) patients were treated with diverting stoma. Early postoperative complication 
with abdominal sepsis was observed in one patient (5%), whereas five (25%) had complications 
requiring surgery later. The majority (57%) had a three stage surgical procedure, yet a diverting stoma 
was omitted in four patients due to technical difficulties with a short ileum mesentery. In the 
questionnaire five patients (25%) stated occasional consideration of pouch removal, but had never 
requested a pouch removal. 
Type of surgery and postoperative complications did not correlate with EF or transit time (data  
not shown). 
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Table 1. Patient characteristics and baseline results. 
Variable 
Descriptive Statistics  
n = 21 
Sex (M/F) 9/12 
Age (years) 41.3 (25.8–67.9) 
BMI 23.8 (18.7–36.1) 1 
Top-study (days) 932 (481–3491) 
Smoking (%) 
Yes 1 (5) 
No 11 (52) 
Earlier 9 (43) 
Extra intestinal symptoms (%) 10 (48) 
Diverting stoma after IPAA operation (%) 13 (62) 
Laparoscopically assisted/conventional open approach (%) 8/13 (38/62) 
OP stages (%) 
1 3 (14) 
2 6 (29) 
3 12 2 (57) 
Postoperative complications (%) 
Pouchitis 10 (50) 
Ileus requiring surgery 3 (15) 
Leakage 1 (5) 
Fistula requiring surgery 1 (5) 
Perforated ulcer 1 (5) 
SIBDQ 55 (22–67) 
Stool frequency, total 9 (4–25) 
Incontinence, minor and major (%)  
Daytime  
Night time 
6 (29)  
3 (14)  
6 (29) 
Pouch volume (mL) 222.5 (100–360) 
Histology (%) 
No inflammation 2 (10) 
Light inflammation 12 (57) 
Moderate-severe inflammation 7 (33) 
Faecal calprotectin (mg·kg−1) 200.5 (19–3750) 
Values are medians (range) unless otherwise indicated. BMI: Body Mass Index. OP-stages: Number of surgical 
steps in performing the ileal pouch anal anastomosis. Op-study: Time in days from pouch surgery to inclusion 
in this study. IPAA: Ileal Pouch-Anal Anastomosis. SIBDQ: Short Inflammatory Bowel Disease 
Questionnaire. 1 Only 20 observations; 2 Four without a diverting stoma. 
3.2. Pouch Function, SIBDQ, and Inflammation 
The patients had a median (range) 24-hour stool frequency of nine (4–25) and daytime incontinence 
was seen in three patients (14%), one major incontinence and two minor (data not shown). The median 
pouch volume was 222.5 mL (100–360) and found to correlate inversely with stool frequency  
(p = 0.017; coefficient = −6.1) in a univariate analysis (data not shown). Median SIBDQ was  
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55 (22–67) with no intersexual difference. Ten patients (48%) had previously experienced, but none 
reported symptoms suggestive of pouchitis during the study. Histology showed moderate to severe 
inflammation in seven (33%) patients and 16 (75%) had a faecal calprotectin above 50 mg·kg−1. Stool 
frequency, pouch volume, and histology were included in both uni-and multivariate analyses and listed 
in Table 3. SIBDQ, incontinence, and faecal-calprotectin showed no correlation with the scintigraphic 
results (data not shown). 
3.3. Scintigraphic Assessments 
To simplify the reading, the mean transit time of the individual is only called “transit time” and the 
“median transit time” refers to the median of all patients. 
The median intestinal transit time ݐ௦̅௜  was 188 min (105–365) and the median β-parameterwas  
45.5 min. EF for evacuation 10 min after filling and one hour later was 49% (3–77) and 62% (17–98), 
respectively. All patients were able to defer the urge to defaecate after instillation. Scintigraphic 
retrograde evacuation into the afferent ileum was observed in 11 patients (52%). 
All scintigraphic results are listed in Table 2 including the median transit time ݐ௚̅௔௦௧௥௜௖ for gastric 
emptying and time for 10% of total activity in the pouch. 
Table 2. Scintigraphic results including 20 patients. 
Median Small Intestinal Transit Time (min) 188.5 (105–365) 
Evacuation fraction A (%) 49 (3–77) 
Evacuation fraction B (%) 62 (17–98) 
Median gastric transit time, ݐ௚̅௔௦௧௥௜௖ (min) 78 (40–115) 
Interval from mouth to 10% in pouch (min) 172.5 (90–270) 
Median spectrum of transit times, β (min) 45.5 (16.7–166.7) 
Values are medians (range) unless otherwise indicated. Evacuation fraction A is analysed from scintigrams 
right after defaecation whereas Evacuation fraction B is derived from scintigrams one hour after the first 
defaecation. Median small intestinal transit time refers to the median of the mean small intestinal transit time 
from the patients. 
The univariate analyses with transit time and EF as dependent variables showed no significant 
correlations, however, when adjusting for potential clinical confounders, we found a higher BMI to 
indicate a significantly longer transit (Ptransit = 0.007; coefficient = 10.7). Moreover, stool frequency 
affected the transit time inversely (Ptransit = 0.02; coefficient = −10.2). In the multivariate analyses with 
EF as dependent variable we found no significant results. 
The variables included in both the univariate and the multivariate analyses are listed in Table 3. 
  
Diagnostics 2015, 5 407 
 
Table 3. Selected results from univariate and multivariate analyses. 
Variable Univariate (n = 20) Multivariate (n = 20) 
Association with transit time R2 Coefficient 95% CI Ptransit Coefficient 
R2 = 0.70  
95% CI 
Ptransit 
Sex 0.06 35.5 −31 to 102 ns 67.5 −5.8 to 140 0.067 
Age 0.16 2.6 −0.4 to 5.6 0.081 2.8 −0.6 to 6.2 0.097 
BMI 0.18 6.4 −0.2 to 13 0.057 10.7 3.6 to 17.7 0.007 
Stool frequency 0.01 1.4 −5.0 to 7.7 ns −10.2 −18.3 to −2.0 0.02 
Pouch volume 0.004 0.01 −0.6 to 0.5 ns −0.4 −1.0 to 0.2 ns 
Histological inflammation—severe 0.08 8.2 −116 to 132 ns −26.0 −140 to 88 ns 
Evacuation fraction A 0.01 −0.4 −2.0 to 1.2 ns −0.8 −4.7 to 3.2 ns 
Evacuation fraction B 0.02 −0.4 −2.1 to 1.2 ns −0.9 −4.9 to 3.1 ns 
Association with evacuation fraction A R2 Coefficient 95% CI PEF Coefficient 
R2 = 0.92  
95% CI 
PEF 
Sex 0.05 9.5 −10.1 to 29.1 ns 9.4 −21.0 to 39.8 ns 
Age 0.06 0.5 −0.4 to 1.4 ns 0.5 −0.9 to 1.9 ns 
BMI <0.01 −0.1 2.4 to 2.2 ns 0.7 −2.3 to 3.6 ns 
Stool frequency 0.01 −0.3 −2.2 to 1.5 ns −2.2 −5.2 to 0.9 ns 
Pouch volume 0.04 −0.1 −0.2 to 0.1 ns −0.1 −0.4 to 0.1 ns 
Histological inflammation—severe 0.06 16.4 −20.2 to 52.9 ns 3.2 −44.1 to 50.5 ns 
Evacuation fraction A is analysed from scintigrams right after defaecation whereas Evacuation fraction B is 
derived from scintigrams one hour after the first defaecation. In transit time analyses only 20 patients are 
included, and 21 patients in analyses of evacuation fraction. Ptransit: p-value between the variables and transit time. 
PEF: p-value between the variables and evacuation fraction A. BMI: Body Mass Index. ns: Not significant. 
4. Discussion 
Determination of small intestinal transit time by means of a scintigraphic technique offers several 
advantages. These include the non-invasive procedure and the possibility to adjust the properties of the 
radiolabelled markers in accordance with various needs (i.e., liquids, solids). The calculation of the 
transit time is independent of gastric emptying and pouch filling in the method outlined here. Moreover, 
the transit time can be calculated without complete emptying of the small intestine. The convolution 
technique was preferred instead of the more simple technique where small intestinal transit is calculated 
based on time to filling of the terminal ileum. The convolution method is superior in terms of minimizing 
the effect of variable emptying of the stomach [19]. 
Further knowledge about the differentiated transit times (mean and spectrum) of the small intestinal 
can be gained through modelling. This provides the option of characterising the transit time. When using 
a method based on time to filling of the pouch the transit time of the front of the radiolabelled meal is 
estimated. This may not reflect the transit time of the whole bulk of meal. The deconvolution principle 
offers the opportunity to compute the small intestinal impulse response, which is the expected small 
intestinal time-activity curve if gastric emptying of the radiolabelled meal were instantaneous, which 
obviously it is not. The small intestinal impulse response yields the spectrum of all possible transit times 
from which a mean value can be calculated. 
Diagnostics 2015, 5 408 
 
The procedures were well tolerated by the patients, clinically applicable and attempted to be as 
physiologic authentic as possible. 
We evaluated transit time and the degree of pouch evacuation in relation to self-reported stool 
frequency, incontinence, and QoL as well as pouch volume and histologic inflammation. We found no 
correlation in univariate analyses and in multivariate analyses only BMI and stool frequency were 
correlated with the transit time. 
Stool frequency and incontinence were used as measures for pouch function as in similar scintigraphic 
pouch studies. Although Öresland score [3] and Cleveland score [4] are examples of tools to estimate 
pouch function, there is no general agreement on how to define symptoms of pouch function in the 
literature. However, it is generally accepted that the number of bowel movements is a measure of pouch 
function. We found a median stool frequency of nine, which is substantially higher than the mean stool 
frequency showed by Zeeuw et al. [1] in a systematic review from 2012. Our patients were invited  
to participate voluntarily and perhaps a poor function was overrepresented among the responders, in  
their hope of an improvement. Moreover, there were slight differences between patients enrolled in the  
review and our population in regard of indication for pouch surgery, anastomosis technique and  
surgical approach. 
We found major and minor incontinence being more frequent at night compared to daytime with 
incidences of 29% and 14%, respectively. This correlates well with a new study from Belgium, finding 
nightly and daily incontinence in 39% and 13% respectively [20]. 
Pouch volume was found to correspond inversely with stool frequency, which corresponds with other 
studies in the literature [6,7]. 
Five patients had a SIBDQ score equal to or below 40, though, the median was 55. This is consistent 
with the literature for this patient group and shows that our group is not invalidated by the life with an 
IPAA [21,22]. Yet, it is important to remember that SIBDQ is mainly a tool for extracting changes in QoL 
in relation to disease activity, whereas a single score only qualifies as an approximation. 
Pouchitis is experienced in approximately 50% of all IPAA patients with ulcerative colitis as the 
primary indication for surgery [18,23]. This was also the case in our study; however none of the patients 
had clinical symptoms compatible with pouchitis in the study period. We did not observe any endoscopic 
signs of pouchitis; yet, it is interesting that nearly all had histological inflammation in various degrees and 
even that 33% showed moderate to severe degree of inflammation. The faecal-calprotectin was elevated in 
the majority of patients and only four (20%) had a value below the Danish threshold of 50 mg·kg−1. 
Nonetheless this was not related to the histological findings; two out of four patients with normal values 
showed slight inflammation and the other two had moderate to severe inflammation. These unknown 
inflammatory findings could be contributing to the functional disorders. 
Scintigraphy 
The method outlined in this paper was first described in 1999 by Brinch et al. [18] who made studies 
on individuals with a healthy colon. Using the method for IPAA patients is not described previously to 
our knowledge. Soper et al. [15] conducted a study in 1989 using NaCl containing 111In-DTPA instilled 
directly into duodenum right after ingestion of a meal. They found the time to first arrival in the pouch 
to be 178 ± 26 min. Their method involves a duodenal catheter and describes the transit time as the time 
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to first arrival of tracer in the pouch. Their result is very similar to ours. Similar to us they did not find 
any correlation between the transit time and the stool frequency; nevertheless, they found the two 
subjects with the highest stool frequency to have the fastest transit. In contrary, the patient with the 
highest stool frequency in our study had the longest transit time, although this was not the tendency 
throughout our study. Hence, it may be a random finding or indicate that the explanation of the functional 
disorders is to be found elsewhere. This theory is strengthening by some patients evacuating before any 
stool has reached the pouch. The similarity in the results indicates that the method of administration; i.e., 
ingestion or instillation, is of minor concern; thus, an oral approach may be more clinically applicable. 
In another study from 1997, Goldberg et al. [14] compared patients with good and poor pouch 
function, respectively, with a threshold of six bowel movements per 24-hour. They investigated the time 
to pouch filling and excluded incontinent patients. They showed an overall median stool frequency lower 
than that in our patients (3–11); but when extracting only data in their “poor-function” group, the 
frequency was similar to ours. They found no intergroup difference in the transit time, which is 
confirmed by our study. In contrary with Goldberg et al. [14], we motivated the eating of a meal three 
hours after ingestion of the tracer-labelled omelette. This second meal is suggested in the SNMMI and 
EANM guidelines [19,23] to minimize prolonged stasis of activity in the terminal ileal reservoir. This 
could potentially affect the transit time, but probably has minor effect due to the three-hour delay. Only 
one patient declined a second meal after approximately 3 h, hence the potential effect on the transit time 
was consistent. 
Only a solid tracer was used in this study compared to Soper and Goldberg [14,15], who used a dual 
tracer technique. The gastric emptying is the most problematic issue when measuring small intestinal 
transit time using an oral agent. Using a dual tracer minimizes this. The deconvolution method also 
eliminates the dependency of gastric emptying; hence a liquid tracer was omitted in the present study. 
Traditionally, radiologic methods have been used for defaecography, but scintigraphic methods are 
still used and have advantages in terms of the adaption for various settings (i.e., need of solid  
faecal-like investigations). Mariani et al. [24] concluded in 2008 that scintigraphic defaecography is 
appropriate for investigating pouch dysfunction with no particular discomfort for the patients. 
The EF in other studies is highly diverging (28%–77%) [8,25,26] and variations are found in terms 
of the type of paste instilled, design of the pouch, and diagnosis of the subjects, which makes a 
comparison difficult. Other studies have shown that J-pouches compared with W-pouches are not 
emptied as efficiently and have a tendency towards increased retrograde evacuation, but this is not 
specified in all studies. A stapled J-pouch is the choice of design and anastomosis today and our study 
population was homogenous in terms of this and the patient diagnosis. Our studyPouch emptying and 
motility may not be linked. It is possible to evacuate the pouch before any stool has reached the rectum. 
This may suggest that the stimulating mechanism for evacuation is outside the rectum. 
Despite the lack of positive relations the study provides valuable information on expected EF and 
transit time in IPAA patients. A systemic review on IPAA complications from 2012 comparing studies 
before and after year 2000 showed a decline in pouch failure after 2000 [1]. Thus it is important to 
visualize any changes in scintigraphic measured EF and transit times, as there are no newer studies. 
An advantage of our study is the simple clinical method that is well tolerated by the patients.  
The simple oral ingestion makes it possible to apply the method to other populations. Only one 
investigator did the scintigraphic analyses in order to ensure standardisation, however, this may also 
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increase the risk of systematic bias. The study was not designed for evaluation of possible intra- and 
inter-observer variation; this could be interesting in future studies in evaluation of the reproducibility of 
the results. 
The relatively small sample size may be part of the explanation for the discrepancy in the results of 
the uni- and multivariate analysis, although we believe confounding to be the major contributor. 
Important associations can also be concealed due to the size. Worth of note, however, the number of 
patients is in line with other studies in this field [14,15]. 
5. Conclusions 
In summary, scintigraphic measurement of intestinal transit time and pouch EF is feasible in a simple 
clinical setting. Our cross sectional study shows no relation between functional outcome and intestinal 
transit time. Objective factors of the pouch functionality are still warranted, and maybe the pouch volume 
or maybe histological changes should be investigated more intensely. 
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